Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

China Jo-Jo Regains Compliance With NASDAQ Minimum Bid Price Requirement

China Jo-Jo Drugstores, Inc. (CJJD), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, announced that The NASDAQ Stock Market LLC notified the company in a letter dated December 14, 2012, that it has regained full compliance with the NASDAQ Capital Market's minimum bid price requirement for continued listing.

The letter noted that as of December 13, 2012, the company's common stock evidenced a closing bid price at or in excess of the $1.00 minimum requirement for at least ten consecutive trading days. Accordingly, the Company has regained compliance with NASDAQ Listing Rule 5550(a)(2), and the matter is closed.

Click here to receive FREE breaking news email alerts for China Jo-Jo Drugstores and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. After ending the previous session modestly lower, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day more than offset yesterday's losses, lifting the major averages to their best closing levels in a month. Sen. Lindsey Graham, R-S.C., is seen as a long shot for the Republican presidential nomination in 2016, and his chances may have gotten worse after he was recorded joking about the prospects for "white men" if he were elected president.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.